1. 1955. Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study. (15th December 2022) Authors: Scott, Robert; Thackwray, Susan; Hourguettes, Nicholas; Gelderblom, Huub; Kanesa-thasan, Niranjan Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗